|1.||Chopra, K: 1 article (11/2007)|
|2.||Kulkarni, S K: 1 article (11/2007)|
|3.||Bishnoi, M: 1 article (11/2007)|
|4.||Hsu, Kang: 1 article (08/2004)|
|5.||Wang, David: 1 article (08/2004)|
|6.||Lin, Hen-I: 1 article (08/2004)|
|7.||Chu, Shi-Jye: 1 article (08/2004)|
|8.||Chang, Deh-Ming: 1 article (08/2004)|
|9.||Lin, Shih-Hua: 1 article (08/2004)|
|10.||Satyanarayana, Padi S V: 1 article (03/2003)|
03/01/2003 - "The aim of the present study was to investigate the effects of the synthetic antioxidant U-74500A, a 21-aminosteroid in a rat model of renal ischemia-reperfusion injury. "
03/01/2003 - "These results clearly demonstrate the in vivo antioxidant effect of U-74500A, a 21-aminosteroid in attenuating renal ischemia-reperfusion injury."
03/01/2003 - "Effect of U-74500A, a 21-aminosteroid on renal ischemia-reperfusion injury in rats."
10/01/1996 - "The lazaroid U74500A is a 21-aminosteroid that inhibits lipid peroxidation and attenuates ischemia-reperfusion injury. "
01/27/1996 - "The heart pretreated with U74500A showed less ischemia-reperfusion injury, better ventricular function, and a lower lipid peroxide level. "
|2.||Acute Lung Injury
08/01/2004 - "Protective effect of U74500A on phorbol myristate acetate-induced acute lung injury."
08/01/2004 - "1. The present study was designed to determine whether U74500A could ameliorate acute lung injury (ALI) induced by phorbol myristate acetate (PMA) in our rat isolated lung model compared with any amelioration induced by dimethylthiourea (DMTU), superoxide dismutase (SOD) and catalase. "
01/01/1996 - "The administration of U74500A prevented lipid peroxidation and preserved pulmonary allograft function after 24 hours of ischemia."
03/01/2003 - "U-74500A markedly attenuated elevated levels of TBARS as well as morphological changes, but did not improve renal dysfunction in rats subjected to renal ischemia-reperfusion. "
04/01/1997 - "A lazaroid compound, U74500A, or a citrate vehicle was given intravenously to each of the six animals for 30 minutes before intestinal ischemia. "
11/01/1996 - "Because lipid peroxidation may cause cell membrane injury after ischemia and reperfusion, we hypothesized that the administration of a lipid peroxidation inhibitor lazaroid (U74500A) would result in an improvement of functional recovery after the 24-hour preservation period. "
11/01/1996 - "The purpose of these experiments was to evaluate the capacity of the lazaroids U-74500A and U-74389F to modify ischemia/reperfusion injury of skeletal muscle in a well-characterized model of high-grade partial ischemia. "
07/01/1990 - "U74500A inhibition of oxidant-mediated lung injury."
|5.||Myocardial Ischemia (Ischemic Heart Diseases)
|8.||Citric Acid (Citrate)
|9.||Thiobarbituric Acid Reactive Substances
|2.||Heart Transplantation (Grafting, Heart)
|3.||Homologous Transplantation (Allograft)